Last update: March 7, 2019
Decreased level of risk
New scientific evidences have driven the Apilam staff to update the level of risk associated to this product.
Former level of risk, which was High Risk probable, is now set to Low Risk probable.
Level of risk reviewed on Feb. 25, 2019
Mild risk possible. Follow up recommended.
Read the Comment.
The leaves of this bush are commonly used and have arbutoside or arbutin as active ingredients. They also contain tannins, flavonoids, ursolic acid and hydroquinone (WHO 1999).
Traditional uses without confirmation from clinical trials: urinary tract anti-inflammatory, urinary antiseptic and diuretic (Moore 2019, EMA 2018, Regrets 2014, WHO 1999, Blumenthal 1998 p225).
At the date of this last update we did not find published data on its excretion in breast milk.
Dehydration (Soliman 2018) and retinopathy (Wang 2004) due to excessive dosage and continuous use have been reported as serious side effects.
Several lactation experts discourage its use during breastfeeding (WHO 1999, Kopec 1999, Blumenthal 1998 p225).
Plant widely used in many cultures, including during pregnancy (Kennedy 2013). Given the lack of toxicity at common doses, moderate and occasional consumption would be compatible with breastfeeding.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.